Splanchnic aspartate metabolism in preterm infants

Withdrawn

• Conditions: Up take of nutrients in the intestine/ Use of nutrients by the intestineBi; 10025477; 10016950; 10028920

• Registration Number: NL-OMON30148
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

Birth weight between 750 and 1500 grams, admitted to the NICU, at least 1 day on full enteral feeding, clinically stable. Intravenous catheter in situ.

Exclusion Criteria

No intravenous catheter in situ, metabolic/congenital disease, abnormal liver or kidney function, clinically instabel, sepsis or NEC. On CPAP or infant flow.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Plasma and expired air enrichment of IV and IG adminstered labelled aspartate.<br /><br>For this purpose we will use two different stable isotopes of aspartate. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>